Singular Genomics Systems, Inc. (CIK: 0001850906) EDGAR, Information, Filings... CompaniesBIO.Com

Singular Genomics Systems, Inc.

Mailing address
3010 SCIENCE PARK ROAD, SAN DIEGO, Delaware, 92121
Phone
(858) 333-7830
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
3826 - (CF Office: Office of Life Sciences) LABORATORY ANALYTICAL INSTRUMENTS
Filings
N/A

Singular Genomics Systems, Inc. (CIK: 0001850906) is an American company incorporated in the state of California. Head office is located at 3010 SCIENCE PARK ROAD, SAN DIEGO, California, 92121. Work in the industry 3826 - (CF Office: Office of Life Sciences) LABORATORY ANALYTICAL INSTRUMENTS. Singular Genomics Systems, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Eisenberg Marcia	0001866723	Aug-04-2023	director
Ropp Sam	0001973313	Apr-11-2023	officer: Chief Commercial Officer
Mardis Elaine R	0001415247	Jan-05-2022	director
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	0001009258	May-26-2021	10 percent owner, other: *Possible Member of 10% Group
Deerfield Mgmt L.P.	0001010823	May-26-2021	10 percent owner, other: *Possible Member of 10% Group
BARKER DAVID L	0001189124	May-26-2021	director
DEERFIELD PARTNERS, L.P.	0001301041	May-26-2021	10 percent owner, other: *Possible Member of 10% Group
Daly David	0001320267	May-26-2021	officer: President and Chief Operating
Flynn James E	0001352546	May-26-2021	10 percent owner, other: *Possible Member of 10% Group
Pellini Michael J	0001402017	May-26-2021	director
Kamdar Kim P.	0001535065	May-26-2021	director
Ryan Jason	0001585017	May-26-2021	director
Deerfield Private Design Fund IV, L.P.	0001680307	May-26-2021	10 percent owner, other: *Possible Member of 10% Group
Deerfield Mgmt IV, L.P.	0001713467	May-26-2021	10 percent owner, other: *Possible Member of 10% Group
Alexandria Venture Investments, LLC	0001722024	May-26-2021	10 percent owner
Velarde Jorge	0001859016	May-26-2021	officer: Senior Vice President
Durie Daralyn	0001859027	May-26-2021	officer: General Counsel
Meeter Dalen	0001859032	May-26-2021	officer: Vice President, Finance
Brancaccio Vincent	0001859094	May-26-2021	officer: Vice President, HR
Glezer Eli N.	0001859694	May-26-2021	officer: Chief Scientific Officer
Spaventa Andrew	0001859701	May-26-2021	director, 10 percent owner, officer: Chief Executive Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Singular Genomics Systems, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SCHEDULE 13G/A	Document	Acc-no: 0001072613-25-000406 (34 Act) Size: KB	May-15-2025	005-92575 25955196
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-25-005952 ( Act) Size: 0 KB	Feb-27-2025
8-K	Document	Current report filing Acc-no: 0001193125-25-038756 (34 Act) Size: KB	Feb-27-2025	001-40443 25676933
SCHEDULE 13D/A	Document	Acc-no: 0001193805-25-000238 (34 Act) Size: KB	Feb-25-2025	005-92575 25665810
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027112 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027107 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027106 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027105 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027101 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027099 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027098 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027096 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027092 ( Act) Size: 0 KB	Feb-25-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-027089 ( Act) Size: 0 KB	Feb-25-2025
EFFECT	Document	Acc-no: 9999999995-25-000510 (33 Act) Size: KB	Feb-21-2025	333-266221 25653999
25-NSE	Document	Acc-no: 0001354457-25-000126 (34 Act) Size: KB	Feb-21-2025	001-40443 25648661
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-25-031333 (33 Act) Size: KB	Feb-21-2025	333-278032 25648501
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-25-031324 (33 Act) Size: KB	Feb-21-2025	333-270228 25648500
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-25-031319 (33 Act) Size: KB	Feb-21-2025	333-263535 25648499
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-25-031315 (33 Act) Size: KB	Feb-21-2025	333-259064 25648497

Recent 20 filings. View all Singular Genomics Systems, Inc. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Singular Genomics Systems, Inc. overview
Singular Genomics Systems, Inc. job
Singular Genomics Systems, Inc. stock
Singular Genomics Systems, Inc. ownership
Singular Genomics Systems, Inc. CEO
Singular Genomics Systems, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.